Higher mDNAsi levels were associated with GBM, IDH wild-type, absence of 1p19q co-deletion, unmethylated MGMT promoter, TERT expression, grade 3 and 4, patient’s vital status as dead, Chr7+/Chr10–, chromosomes 19/20 co-gain, ATRX wildtype and ME and CL transcriptome subtypes (Table 3). This evidence concerns the gene MGMT and glioblastoma.